380 Shares in CME Group Inc. (NASDAQ:CME) Acquired by New Covenant Trust Company N.A.

New Covenant Trust Company N.A. purchased a new position in CME Group Inc. (NASDAQ:CME) during the first quarter, HoldingsChannel reports. The fund purchased 380 shares of the financial services provider’s stock, valued at approximately $82,000.

A number of other institutional investors and hedge funds have also modified their holdings of the company. B. Riley Wealth Advisors Inc. lifted its stake in CME Group by 1.3% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after buying an additional 48 shares in the last quarter. Capital Advisors Ltd. LLC lifted its stake in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after buying an additional 48 shares in the last quarter. Lantz Financial LLC lifted its stake in CME Group by 1.1% in the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after buying an additional 49 shares in the last quarter. Transcend Capital Advisors LLC lifted its stake in CME Group by 1.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock valued at $631,000 after buying an additional 50 shares in the last quarter. Finally, Greystone Financial Group LLC lifted its stake in shares of CME Group by 1.6% during the 4th quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after purchasing an additional 52 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other CME Group news, insider Hilda Harris Piell sold 7,140 shares of the company’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the sale, the insider now directly owns 29,256 shares of the company’s stock, valued at $6,153,999.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Charles P. Carey sold 3,000 shares of the stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares in the company, valued at $1,399,936.72. The disclosure for this sale can be found here. Insiders sold 14,290 shares of company stock valued at $2,957,300 over the last quarter. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

NASDAQ:CME traded up $2.60 during mid-day trading on Thursday, hitting $196.31. The company’s stock had a trading volume of 1,860,673 shares, compared to its average volume of 1,956,907. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $70.69 billion, a price-to-earnings ratio of 22.33, a P/E/G ratio of 6.30 and a beta of 0.52. The stock has a fifty day moving average of $198.68 and a 200-day moving average of $206.91.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the business posted $2.30 earnings per share. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. As a group, equities analysts forecast that CME Group Inc. will post 9.8 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Friday, June 7th were given a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.34%. The ex-dividend date of this dividend was Friday, June 7th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft reduced their price target on CME Group from $195.00 to $193.00 and set a “hold” rating on the stock in a research note on Thursday, July 25th. Rosenblatt Securities reissued a “sell” rating and set a $187.00 price target (up previously from $185.00) on shares of CME Group in a research note on Thursday, April 25th. JPMorgan Chase & Co. increased their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Keefe, Bruyette & Woods increased their price target on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Finally, Morgan Stanley increased their price target on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 9th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $212.64.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.